4-Aminoquinoline-Based Adamantanes as Potential Anticholinesterase Agents in Symptomatic Treatment of Alzheimer’s Disease

Considering that acetylcholinesterase (AChE) inhibition is the most important mode of action expected of a potential drug used for the treatment of symptoms of Alzheimer’s disease (AD), our previous pilot study of 4-aminoquinolines as potential human cholinesterase inhibitors was extended to twenty-...

Descripción completa

Detalles Bibliográficos
Autores principales: Komatović, Katarina, Matošević, Ana, Terzić-Jovanović, Nataša, Žunec, Suzana, Šegan, Sandra, Zlatović, Mario, Maraković, Nikola, Bosak, Anita, Opsenica, Dejan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229919/
https://www.ncbi.nlm.nih.gov/pubmed/35745878
http://dx.doi.org/10.3390/pharmaceutics14061305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229919/
https://www.ncbi.nlm.nih.gov/pubmed/35745878
http://dx.doi.org/10.3390/pharmaceutics14061305

Ejemplares similares